Catalyst Wire Dossier Catalyst Wire Dossier

AVT80

vedolizumab · Alvotech Swiss AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVT80, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio [Phase 1]

See pricing